"This marks the most significant federal policy on this in more than five decades." — Brian Fitzpatrick, CEO of Qredible Subscribe to Qredible Live About This Episode On December 18th, President Trump signed an executive order directing the rescheduling of cannabis from Schedule 1 to Schedule 3—a move that has generated both excitement and confusion […]
Speculation about government health insurance covering CBD treatments created brief excitement across the hemp industry last week, but the reality emerging from proposed Medicare policy changes tells a far more limited story. The Centers for Medicare & Medicaid Services proposal published in the Federal Register in early December 2025 would cover only a narrow list […]
A new U.S. Supreme Court decision is sending a clear message to cannabis, CBD, and hemp businesses: product claims, testing practices, and quality controls are now firmly under the national compliance microscope. In Medical Marijuana, Inc. et al v. Horn (2025), the Court ruled that a fired truck driver can sue CBD manufacturers under the […]
The Drug Enforcement Administration has begun promoting an advertising campaign from a Trump-linked nonprofit organization warning about marijuana laced with fentanyl. The campaign attributes overdose deaths to contaminated cannabis products, raising significant questions about the accuracy and intent of federal drug policy messaging. The Advertisement's Central Claim The promoted advertisement features a stark narrative. "Best […]
The United States Supreme Court ruled 5-4 on October 29, 2025, that a truck driver who lost his job after taking a hemp-based supplement can use federal anti-racketeering law to sue the manufacturer he said falsely advertised its product as not containing THC, according to USA TODAY reporting. Case Background and Core Dispute Douglas Horn […]
Suntory CEO Resigns After Investigation Into CBD Supplement, Maintains Innocence Meta Description: Former Suntory Holdings CEO Takeshi Niinami resigns amid police investigation into US-imported CBD supplement in Japan, where cannabis derivatives face strict legal restrictions despite growing global CBD market acceptance. Takeshi Niinami, former chief executive of Japanese beverage giant Suntory Holdings, has resigned his […]
For years, the nutraceutical and CBD industries have operated in a gray zone—booming with innovation but light on oversight. That era is ending. During a recent Qredible Live Broadcast, CEO Brian Fitzpatrick and CRO Noah Fitzgerald discussed how rising regulatory pressure on nutraceuticals and adjacent markets like peptides and CBD is reshaping the health and […]
While traditional cannabis businesses face increasing financial headwinds, the hemp and CBD sectors are experiencing notable growth and investment interest. This market divergence has become one of the most fascinating developments in the broader cannabis industry. During a recent Qredible Live Broadcast, Peter Su, Director of Specialty Banking for Hanover Bank, and Mike Goral, Partner […]
In the CBD industry, those three letters—C-O-A—represent perhaps the most crucial document your business will handle. A Certificate of Analysis isn't just paperwork; it's your brand's credibility, compliance shield, and customer trust builder all wrapped into one. With heightened regulatory scrutiny and growing consumer awareness, mastering COA management has become essential for CBD businesses looking […]
When buying CBD products, quality and safety should be top priorities. A Certificate of Analysis (COA) is a crucial document that verifies a product’s contents and confirms that it meets regulatory standards. But if you’re unfamiliar with lab reports, reading a COA can feel overwhelming. This guide will help you break down the essential sections […]
